Westwood, MA, United States of America

Nelson Ruiz-Opazo

USPTO Granted Patents = 12 


 

Average Co-Inventor Count = 2.3

ph-index = 3

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2005-2025

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Nelson Ruiz-Opazo

Introduction

Nelson Ruiz-Opazo is a prominent inventor based in Westwood, MA, known for his significant contributions to medical science. He holds a total of 12 patents, showcasing his innovative approaches to treating various diseases, particularly those related to neutrophil activation and coronavirus infections.

Latest Patents

Among his latest patents, one focuses on methods for treating NETosis and neutrophil activation. This patent describes methods and compositions that inhibit neutrophils, specifically targeting NET release or NETosis through the use of a DEspR inhibitor, such as an anti-DEspR antibody reagent. These methods are particularly relevant for treating diseases like cancer, where neutrophils contribute to disease progression. Another notable patent involves antibody therapies for treating coronavirus infections. This patent outlines various methods for improving survival rates in subjects with COVID-19, as well as strategies for preventing organ dysfunction associated with the virus.

Career Highlights

Throughout his career, Nelson has worked with esteemed institutions, including Boston University and Nomi Corporation. His work has significantly impacted the field of immunology and therapeutic development, particularly in the context of infectious diseases and cancer treatment.

Collaborations

Nelson has collaborated with notable colleagues, including Victoria L. M. Herrera and Francis Joseph Carr, contributing to a rich exchange of ideas and advancements in their respective fields.

Conclusion

Nelson Ruiz-Opazo's innovative work and numerous patents reflect his dedication to advancing medical science and improving patient outcomes. His contributions continue to influence the development of new therapies for critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…